Pancreatic and Bile Duct Stone Management Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 1.45 Bn

Forecast Year, 2035

USD 2.28 Bn

CAGR, 2026 - 2035

4.62%

Report Coverage

Global

What is the Pancreatic and Bile Duct Stone Management Market Size in 2026?

The global pancreatic and bile duct stone management market size was calculated at USD 1.45 billion in 2025 and is predicted to increase from USD 1.52 billion in 2026 to approximately USD 2.28 billion by 2035, expanding at a CAGR of 4.62% from 2026 to 2035. The market is driven by rising gallstone prevalence and growing adoption of minimally invasive endoscopic treatments.

Key Takeaways

• By region, North America accounted for the largest share of the market in 2025.
• By region, Asia Pacific is expected to witness the fastest growth during the forecasted years.
• By product, the extraction balloon catheters segment held a significant share of the market in 2025.
• By product, the electrohydraulic/laser lithotripsy segment is expected to grow at a significant rate in the market over the forecast period.
• By indication, the pancreatic stones segment held a significant share of the market in 2025.
• By indication, the bile duct stones segment is expected to show considerable growth in the market over the forecast period.
• By end user, the hospitals segment held a significant share of the market in 2025.
• By end user, the ambulatory surgical centers segment is expecetd to show considerable growth in the market over the forecast period.

Market Overview

The pancreatic and bile duct stone management market is a branch of the healthcare sector that deals with the diagnosis, treatment, and removal of stones that develop in the pancreatic duct and the bile duct. The rising prevalence of gallstones and pancreatic diseases is a major factor driving the growth of the market, as these diseases prompt the need for effective treatment methods. Advancements in imaging and endoscopic devices have significantly improved diagnostic accuracy and treatment success, increasing their clinical adoption. Moreover, rising healthcare awareness, accessibility to specialized care, expanding healthcare infrastructure, and ongoing technological innovation are contributing to market growth.

Why is AI Integral in Pancreatic and Bile Duct Stone Management?

Application of artificial intelligence is continuously transforming the way pancreatic and bile duct stone treat and managed by enhancing the precision of the diagnoses, treatment plans, and reducing the efficiency of the treatment. AI is employed to identify stones more conveniently and precisely through CT scans and MRIs, as well as endoscopic images, where the automated interpretation of the results can eliminate mistakes and lost cases. Risk factors of patients, disease progression forecasts, and individualized treatment plans are also being considered with the aid of predictive analytics tools. The AI incorporation also helps to optimize workflow; therefore, the process takes a shorter time, and the resources are utilized more efficiently within the healthcare setting.

Pancreatic and Bile Duct Stone Management Market Trends

• Increasing use of minimally invasive endoscopic interventions is changing the nature of pancreatic and bile duct stone care since care providers are increasingly adopting approaches that can reduce hospital admission, minimize the incidence of complications, enhance accuracy, and better patient recovery outcomes.
• Ongoing technological advances in diagnostic imaging are enable earlier detection of pancreatic and bile duct stones, improving treatment planning, minimizing procedural risks, ensuring timely intervention, and enhancing clinical efficiency and patient management.
• The increasing rates of gallstones, chronic pancreatitis, and lifestyle-related stomach issues are boosting the demand for high-tech stone management, which in turn prompts healthcare systems worldwide to expand their services, invest in equipment, and raise the level of access to the treatment.
• Growing patient awareness of early detection and complications encourages timely medical consultation, higher screening rates, and broader acceptance of preventive and therapeutic measures globally.
• There is a rising demand for lithotripsy devices, smart endoscopic systems, and integrated treatment platforms that enhance procedural efficacy, aid in removing complex stones, reduce recurrence, and drive continuous innovation and competitive advantages in healthcare markets worldwide.

Market Scope

Segment Insights

Product Insights

Why Does the Extraction Balloon Catheters Segment Lead the Market?

The extraction balloon catheters segment led the pancreatic and bile duct stone management market by holding the largest share in 2025. This is because of their widespread clinical use, reliability of the procedure, and great potency in the removal of small to medium-sized stones. These catheters are widely applied in endoscopic practice since they enable stone capture and removal with the least amount of trauma in the surrounding tissues. The ease of use, high success rate, and their compatibility with conventional endoscopic machines make them the option of choice among gastroenterologists. Furthermore, extraction balloon catheters are relatively cheap compared to the more complex technology of stone fragmentation, which encourages their application in a huge range of healthcare institutions.

The electrohydraulic/laser lithotripsy segment is expected to grow at a significant CAGR over the forecast period because of its capability to treat complex, large, and impacted pancreatic and bile duct stones that cannot be removed using the normal extraction procedures. Such technologies allow accurately disintegrating stones into smaller fragments so that they are easier to remove, and less invasive surgeries are necessary. The increasing cases of hard-to-treat stones with recurrent or advanced cases are pushing the adoption of high-technology lithotripsy solutions. Technological advances have made procedures more accurate, energy efficient, and precise, with superior outcomes of the clinical results and greater physician confidence.

Indication Insights

Why Did the Pancreatic Stones Segment Contribute the Most Revenue in the Market?

The pancreatic stones segment held the largest share of the pancreatic and bile duct stone management market in 2025, driven by the high clinical complexity and the need for long-term management of pancreatic duct stone disease. Such stones are commonly associated with chronic pancreatitis, which may often necessitate repeated examination procedures, treatment, and monitoring. The necessity of special treatment methods, such as enhanced imaging, endoscopy, and technologies of stone fragmentation, has also contributed to segmental growth. Multidisciplinary care and multiple sessions of the treatment of pancreatic stones are also a frequent practice in pancreatic stone management that leads to increased revenue generation.

The bile duct stones segment is expected to grow at a significant CAGR in the market, owing to the increasing rate of gallstone disease around the world and the rising awareness of the complications that accompany untreated biliary obstruction. Better diagnostic imaging and screening procedures are allowing the detection of stones in the bile duct earlier, leading to increased treatment. Demand for treatment is rising as patients increasingly prefer early intervention to prevent infection, inflammation, and other severe complications. Additionally, the growing prevalence of these conditions is driven by aging populations and lifestyle-related factors, including metabolic disorders and obesity.

End User Insights

Why Did the Hospitals Segment Lead the Pancreatic and Bile Duct Stone Management Market?

The hospitals segment led the market, accounting for the largest revenue share in 2025, because of their offerings like high-level clinical services, availability of specialized facilities, and ability to manage complex cases. Hospitals serve as primary centers for diagnostic assessments, endoscopic treatments, and emergency care, equipped with high-end imaging, surgical support, and multidisciplinary teams to manage high-risk and complex pancreatic and bile duct conditions. Many procedures require specialized devices and trained personnel, making hospitals the preferred setting for these treatments.

The ambulatory surgical centers segment is expected to grow at a significant CAGR over the forecast period, as a large number of people seek cost-effective, convenient, and minimally invasive treatment methods. Outpatient endoscopy centers offer same-day procedures, allowing patients to return home quickly, reducing hospitalization time and overall healthcare costs. These facilities are favored by patients and practitioners for shorter waiting times, streamlined operations, and lower risk of hospital-acquired complications. The growing adoption of outpatient care models also helps optimize resource utilization and ease the burden on hospitals.

Regional Insights

North America Pancreatic and Bile Duct Stone Management Market Size and Growth 2026 to 2035

The North America pancreatic and bile duct stone management market size is estimated at USD 478.50 million in 2025 and is projected to reach approximately USD 763.80 million by 2035, with a 4.79% CAGR from 2026 to 2035.

What Made North America the Leading Region in the Pancreatic and Bile Duct Stone Management Market?

North America led the pancreatic and bile duct stone management market by holding the largest share in 2025. This is because of its well-developed healthcare system, high uptake of innovative medical technologies, and high volumes of procedures. Widespread availability of minimally invasive endoscopic procedures, supported by strong hospital networks and gastroenterology centers, further drives the market. There is a high prevalence of lifestyle-related digestive disorders, such as gallstones and chronic pancreatitis, which fueled the need for efficient diagnostic and treatment solutions. Favorable reimbursement policies and heightened healthcare spending also contributed to the region's dominance in the market.

U.S. Pancreatic and Bile Duct Stone Management Market Size and Growth 2026 to 2035

The U.S. pancreatic and bile duct stone management market size is calculated at USD 358.88 million in 2025 and is expected to reach nearly USD 576.67 million in 2035, accelerating at a strong CAGR of 4.86% between 2026 and 2035.

U.S. Market Analysis

The U.S. pancreatic and bile duct stone management market is expanding due to continuous technological innovations in imaging and endoscopic devices, improving procedural accuracy and outcomes. Increasing patient awareness about early detection and preventive care is driving more individuals to seek timely treatment. Additionally, high healthcare expenditure, strong R&D investment by medical device companies, and the availability of skilled gastroenterology specialists are further supporting market growth.

Why is Asia Pacific Undergoing the Fastest Growth in the Pancreatic and Bile Duct Stone Management Market?

Asia Pacific is expected to grow at the fastest CAGR in the upcoming period because of the rapid development of healthcare infrastructure, increasing awareness of health and wellness, and increasing accessibility to advanced medical technologies. Rapid urbanization, changing dietary habits, and rising incidence of gallstones and pancreatic diseases are driving market growth. Significant investments in hospital modernization, medical device adoption, and specialized gastrointestinal services are improving treatment accessibility. Additionally, government and private healthcare initiatives, including expanded screening programs and enhanced clinical training, are enabling earlier diagnosis and more effective treatment.

China Market Analysis

China is the major contributor to the Asia Pacific pancreatic and bile duct stone management market due to its large patient population, rising prevalence of digestive and metabolic disorders, and increasing demand for advanced healthcare services. Strong government investments in hospital modernization, specialized gastrointestinal care, and medical device adoption are expanding access to high-quality treatment. Additionally, public health initiatives, early screening programs, and collaborations between private and state-owned healthcare providers are accelerating the adoption of minimally invasive endoscopic procedures, making China the dominant market driver in the region.

Why Is the European Pancreatic and Bile Duct Stone Management Market Experiencing Notable Growth?

Europe is expected to grow at a notable CAGR in the foreseeable future due to the rising adoption of advanced medical technologies and a focus on early disease management. The region's well-developed network of specialty hospitals and diagnostic centers supports widespread use of minimally invasive endoscopic treatments. The increasing prevalence of gallstones and chronic pancreatic conditions, particularly among aging populations, is driving demand for effective therapies, while ongoing investment in medical research, digital health integration, and improved imaging continues to enhance diagnostic accuracy and procedural outcomes.

Pancreatic and Bile Duct Stone Management Market Companies

• Boston Scientific Corporation
• Argon Medical Devices
• Olympus Endoscopy
• Cook Medical
• Medtronic Inc.
• Conmed Endoscopic Technologies
• CR BARD Inc (Becton, Dickinson and Company)
• Cordis (Cardinal Health Inc.)
• Zeon Medical Co., Ltd.
• Medi-Globe (ENDO-Flex) GmbH
• Taewoong Medical Co., Ltd.

Segments Covered in the Report

By Product

• ERCP Catheters
• Guidewires
• Sphincterotomes
• Dilation Balloon Catheters
• Extraction Balloon Catheters
• Extraction Basket Catheters
• Biliary Stents
• Self-Expandable Biliary Stents
• Dilation Large-Balloon Catheters
• Mechanical Lithotripsy
• Electrohydraulic/Laser Lithotripsy

By Indication

• Pancreatic Stones
• Bile Duct Stones

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa